Hox-gene expression as a biomarker for igf-1r therapeutics

ECU Author/Contributor (non-ECU co-authors, if there are any, appear on document)
Fred Edmond Bertrand (Creator)
Jarrett Thomas Whelan (Creator)
Institution
East Carolina University (ECU )
Web Site: http://www.ecu.edu/lib/

Abstract: This invention provides methods for treating or preventing the onset of a tumor in a subject , wherein the tumor is determined to overexpress a Hox gene , including administering to the subject a therapeutically or prophylactically effective amount of an insulin-like growth factor-1 receptor (IGF-1R) antagonist. The invention also provides methods for determining whether a tumor in a subject is amenable to treatment with an IGF-1R antagonist including determining whether the tumor overexpresses a Hox gene , wherein overexpression of the Hox gene indicates that the tumor is amenable to treatment with an IGF-1R inhibitor.

Additional Information

Publication
Other
Language: English
Date: 2008
Keywords
cancer, genetics
Subjects

Email this document to

This item references:

TitleLocation & LinkType of Relationship
Hox-gene expression as a biomarker for igf-1r therapeuticshttp://hdl.handle.net/10342/7536The described resource references, cites, or otherwise points to the related resource.